Kentucky Retirement Systems lessened its holdings in Globe Life Inc. (NYSE:GL – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,172 shares of the company’s stock after selling 85 shares during the quarter. Kentucky Retirement Systems’ holdings in Globe Life were worth $688,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in GL. Versant Capital Management Inc grew its holdings in Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock worth $27,000 after acquiring an additional 194 shares during the last quarter. Albion Financial Group UT bought a new stake in Globe Life in the 4th quarter worth $28,000. True Wealth Design LLC bought a new stake in Globe Life in the 3rd quarter worth $59,000. Private Trust Co. NA grew its holdings in Globe Life by 67.5% in the 3rd quarter. Private Trust Co. NA now owns 670 shares of the company’s stock worth $71,000 after acquiring an additional 270 shares during the last quarter. Finally, Intact Investment Management Inc. bought a new stake in Globe Life in the 3rd quarter worth $73,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.
Globe Life Trading Up 0.1 %
Shares of NYSE GL opened at $122.66 on Tuesday. Globe Life Inc. has a 1 year low of $38.95 and a 1 year high of $129.18. The stock has a market cap of $10.30 billion, a P/E ratio of 10.26 and a beta of 0.81. The firm has a 50-day moving average of $116.85 and a 200 day moving average of $109.57. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05.
Insiders Place Their Bets
In other Globe Life news, CEO Frank M. Svoboda sold 14,340 shares of Globe Life stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total value of $1,560,192.00. Following the completion of the transaction, the chief executive officer now directly owns 16,396 shares of the company’s stock, valued at approximately $1,783,884.80. The trade was a 46.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $113.23, for a total transaction of $339,690.00. Following the completion of the transaction, the director now directly owns 5,122 shares of the company’s stock, valued at $579,964.06. This trade represents a 36.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 75,678 shares of company stock valued at $8,799,822. Insiders own 1.51% of the company’s stock.
Wall Street Analysts Forecast Growth
GL has been the topic of a number of recent analyst reports. Wells Fargo & Company raised their price target on shares of Globe Life from $126.00 to $141.00 and gave the stock an “overweight” rating in a report on Wednesday, February 19th. BMO Capital Markets initiated coverage on shares of Globe Life in a research note on Thursday, January 23rd. They set a “market perform” rating and a $114.00 target price on the stock. Morgan Stanley lifted their target price on shares of Globe Life from $123.00 to $125.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 11th. Evercore ISI raised shares of Globe Life from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, Jefferies Financial Group lifted their target price on shares of Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $135.50.
Get Our Latest Analysis on Globe Life
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading
- Five stocks we like better than Globe Life
- What is the Shanghai Stock Exchange Composite Index?
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Price Targets on NVIDIA Rise in Front of Earnings
- Ride Out The Recession With These Dividend KingsĀ
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.